| 2000 |
Bop1 is a WD40 repeat nucleolar protein that cosediments with 50S-80S ribonucleoprotein particles containing 32S rRNA precursor; expression of dominant-negative Bop1Delta (lacking 231 N-terminal amino acids) specifically blocks conversion of 36S to 32S pre-rRNA and completely inhibits processing of 32S pre-rRNA to mature 28S and 5.8S rRNAs, causing deficiency of cytosolic 60S ribosomal subunits and G1 cell cycle arrest. |
Immunofluorescence, sucrose density gradient fractionation, pulse-chase rRNA processing analysis, dominant-negative expression |
Molecular and cellular biology |
High |
10891491
|
| 2001 |
Perturbation of Bop1 by dominant-negative Bop1Delta induces p53-dependent G1 cell cycle arrest; inactivation of p53 abrogates this arrest without restoring normal rRNA processing, demonstrating that deficiencies in ribosome synthesis trigger cell cycle arrest via a p53-dependent nucleolar stress pathway, and that rRNA processing defects can be uncoupled from cell cycle arrest. |
Dominant-negative expression, p53 inactivation, CDK kinase activity assays, pRb phosphorylation analysis, p21/p27 western blotting |
Molecular and cellular biology |
High |
11390653
|
| 2001 |
The yeast homolog of Bop1, Erb1p (encoded by YMR049C), is essential for viability and required for processing of 27SB pre-rRNA to 25S and 5.8S rRNAs; Erb1p depletion causes loss of 25S and 5.8S rRNAs with underaccumulation of 27SB pre-rRNA, demonstrating evolutionary conservation of Bop1/Erb1p function in large ribosomal subunit maturation. |
Gene disruption, conditional depletion, rRNA processing analysis in S. cerevisiae |
Nucleic acids research |
High |
11522832
|
| 2002 |
Bop1 is required for pre-rRNA processing at four distinct sites within ITS1, ITS2, and the 3' external spacer; both C-terminal (Bop1N2) and N-terminal (Bop1Delta) deletion mutants localize to the nucleolus and inhibit rRNA processing and cell cycle progression, and antisense oligonucleotide knockdown of endogenous Bop1 recapitulates processing defects. |
Deletion mutagenesis, antisense oligonucleotide knockdown, immunofluorescence, rRNA processing analysis |
The Journal of biological chemistry |
High |
12048210
|
| 2004 |
Bop1 physically interacts with Pes1 (mouse homolog of yeast Nop7p); this interaction is essential for efficient incorporation of Pes1 into nucleolar preribosomal complexes, and Pes1 mutants defective for Bop1 interaction lose the ability to affect rRNA maturation and the cell cycle. |
Co-immunoprecipitation, dominant-negative Pes1 mutant panel, rRNA processing analysis, cell cycle assays |
Molecular cell |
High |
15225545
|
| 2005 |
Bop1 and Pes1 form a stable trimeric complex with WDR12 (a novel WD40 repeat protein), termed the PeBoW complex; endogenous WDR12 is required for processing of 32S precursor rRNA and cell proliferation, and a dominant-negative WDR12 mutant blocks rRNA processing and induces p53 accumulation in a p19ARF-independent manner. |
Co-immunoprecipitation, dominant-negative expression, rRNA processing assays, p53 accumulation analysis |
The Journal of cell biology |
High |
16043514
|
| 2007 |
Bop1 is the integral/central component of the PeBoW complex: recombinant expression of Pes1, Bop1, and WDR12 is sufficient for complex formation; Bop1 knockdown abolishes copurification of Pes1 with WDR12; overexpressed Bop1 inhibits cell proliferation and rRNA processing (rescuable by WDR12 co-expression but not Pes1); nucleolar transport of Bop1 from cytoplasm is Pes1-dependent, while Pes1 migrates to nucleolus independently of Bop1. |
Recombinant protein expression, co-immunoprecipitation, siRNA knockdown, immunofluorescence, cell fractionation, sucrose gradient centrifugation |
Molecular and cellular biology |
High |
17353269
|
| 2020 |
BOP1 promotes chromosomal instability by increasing the active form of Aurora kinase B (AURKB), which regulates chromosomal segregation; CCAT2 lncRNA directly binds and stabilizes BOP1 protein and also activates MYC-driven BOP1 transcription, leading to BOP1 overexpression that causes chromosomal missegregation errors. |
MS2 pull-down, RNA immunoprecipitation, SHAPE analysis, BOP1 overexpression/knockdown, cytogenetic analysis, immunofluorescence |
Gastroenterology |
Medium |
32805281
|
| 2019 |
Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by downregulating MAPK phosphatases DUSP4 and DUSP6 via a transcription-based mechanism, leading to increased MAPK signaling. |
shRNA screen (363 epigenetic regulators), BOP1 knockdown, DUSP4/DUSP6 expression analysis, MAPK pathway activity assays, in vivo mouse studies |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
30782837
|
| 2011 |
BOP1 promotes epithelial-to-mesenchymal transition (EMT) in hepatocellular carcinoma cells, stimulates actin stress fiber assembly, and activates RhoA; siRNA-mediated BOP1 knockdown upregulates epithelial markers (E-cadherin, cytokeratin 18, γ-catenin) and downregulates mesenchymal markers (fibronectin, vimentin), while ectopic BOP1 expression in hepatocytes increases invasiveness and migration. |
siRNA knockdown, ectopic overexpression, invasion/migration assays, EMT marker western blotting, RhoA activation assay, actin staining |
Hepatology (Baltimore, Md.) |
Medium |
21520196
|
| 2021 |
BOP1 activates Wnt/β-catenin signaling in triple-negative breast cancer by increasing recruitment of CBP (CREB-binding protein) to β-catenin, enhancing CBP-mediated acetylation of β-catenin, and increasing transcription of stemness-related genes CD133 and ALDH1A1, thereby promoting cancer stem cell-like phenotype and chemoresistance. |
BOP1 overexpression/knockdown, Co-immunoprecipitation (BOP1-CBP-β-catenin), acetylation assay, gene expression analysis, in vitro and in vivo drug resistance assays |
The Journal of pathology |
Medium |
33797754
|
| 2021 |
BOP1 knockdown in vascular smooth muscle cells activates nucleolar stress, causing RPL11 release from nucleolus to nucleoplasm, which inhibits MDM2 E3 ubiquitin ligase activity, stabilizes p53, and subsequently inhibits VSMC proliferation and migration; siRNA knockdown of RPL11 or p53 inhibition with pifithrin-α partially reverses these effects. |
siRNA knockdown of BOP1 and RPL11, p53 inhibitor (pifithrin-α), proliferation/migration assays, nascent protein synthesis assay, rat balloon injury model |
Oxidative medicine and cellular longevity |
Medium |
33510838
|
| 2024 |
BOP1 knockdown triggers nucleolar stress response causing RPL11 release from nucleolus into nucleoplasm, inhibiting MDM2, stabilizing p53, which then inhibits mTOR phosphorylation, activating autophagy in granulosa cells; BOP1 overexpression in vivo suppresses this pathway and alleviates PCOS phenotypes. |
BOP1 knockdown/overexpression (lentiviral), RPL11 localization, MDM2 inhibition, p53/mTOR pathway analysis, in vivo PCOS mouse model |
Cellular and molecular life sciences : CMLS |
Medium |
38409361
|
| 2006 |
Transient overexpression of BOP1 in human cells increases the percentage of multipolar spindles, indicating a role for BOP1 in proper chromosome segregation beyond its function in ribosome biogenesis. |
BOP1 overexpression, immunofluorescence analysis of spindle morphology |
Genes, chromosomes & cancer |
Low |
16804918
|
| 2023 |
BOP1 promotes prostate cancer cell viability and metastasis via regulation of DUSP6 expression and activation of the MAPK pathway; BOP1 knockout inhibits DUSP6 expression and MAPK signaling, and DUSP6 overexpression reverses the effects of BOP1 siRNA. |
BOP1 knockout/siRNA, DUSP6 overexpression, MAPK pathway western blotting, Transwell invasion assay, apoptosis assay |
Archivos espanoles de urologia |
Low |
37681336
|
| 2022 |
lncRNA SNHG6 binds BOP1 protein and enhances its stability, promoting glycolysis and proliferation in hepatocellular carcinoma cells; BOP1 overexpression rescues proliferation and glycolysis changes caused by SNHG6 manipulation. |
MS2 pull-down, RNA pull-down, RNA immunoprecipitation (RIP), western blotting, glucose uptake/lactate/OCR/ECAR assays |
Animal cells and systems |
Low |
36605586
|
| 2025 |
BOP1 depletion reduces overall ribosome availability, which preferentially upregulates translation of non-optimal codon transcripts (including several ISGs) during IFN-β stimulation, demonstrating that ribosome biogenesis controlled by BOP1 regulates translational fine-tuning through codon optimality. |
RNA-seq, LC-MS/MS proteomics (multi-omics), BOP1 knockdown, codon usage analysis, reporter constructs (codon-optimal vs non-optimal) |
bioRxivpreprint |
Low |
bio_10.1101_2025.09.05.673799
|